Literature DB >> 23457892

Illicit use of LSD or psilocybin, but not MDMA or nonpsychedelic drugs, is associated with mystical experiences in a dose-dependent manner.

Michael Lyvers1, Molly Meester.   

Abstract

Psychedelic drugs have long been known to be capable of inducing mystical or transcendental experiences. However, given the common "recreational" nature of much present-day psychedelic use, with typical doses tending to be lower than those commonly taken in the 1960s, the extent to which illicit use of psychedelics today is associated with mystical experiences is not known. Furthermore the mild psychedelic MDMA ("Ecstasy") is more popular today than "full" psychedelics such as LSD or psilocybin, and the contribution of illicit MDMA use to mystical experiences is not known. The present study recruited 337 adults from the website and newsletter of the Multidisciplinary Association for Psychedelic Studies (MAPS), most of whom reported use of a variety of drugs both licit and illicit including psychedelics. Although only a quarter of the sample reported "spiritual" motives for using psychedelics, use of LSD and psilocybin was significantly positively related to scores on two well-known indices of mystical experiences in a dose-related manner, whereas use of MDMA, cannabis, cocaine, opiates and alcohol was not. Results suggest that even in today's context of "recreational" drug use, psychedelics such as LSD and psilocybin, when taken at higher doses, continue to induce mystical experiences in many users.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23457892     DOI: 10.1080/02791072.2012.736842

Source DB:  PubMed          Journal:  J Psychoactive Drugs        ISSN: 0279-1072


  15 in total

1.  Finding the self by losing the self: Neural correlates of ego-dissolution under psilocybin.

Authors:  Alexander V Lebedev; Martin Lövdén; Gidon Rosenthal; Amanda Feilding; David J Nutt; Robin L Carhart-Harris
Journal:  Hum Brain Mapp       Date:  2015-05-22       Impact factor: 5.038

Review 2.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

Review 3.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

4.  Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.

Authors:  Gabrielle Agin-Liebes; Trevor F Haas; Rafael Lancelotta; Malin V Uthaug; Johannes G Ramaekers; Alan K Davis
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-23

Review 5.  Predicting Reactions to Psychedelic Drugs: A Systematic Review of States and Traits Related to Acute Drug Effects.

Authors:  Jacob S Aday; Alan K Davis; Cayla M Mitzkovitz; Emily K Bloesch; Christopher C Davoli
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-05

6.  Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI).

Authors:  Matthew M Nour; Lisa Evans; David Nutt; Robin L Carhart-Harris
Journal:  Front Hum Neurosci       Date:  2016-06-14       Impact factor: 3.169

7.  Long-lasting subjective effects of LSD in normal subjects.

Authors:  Yasmin Schmid; Matthias E Liechti
Journal:  Psychopharmacology (Berl)       Date:  2017-09-16       Impact factor: 4.530

8.  Survey of subjective "God encounter experiences": Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.

Authors:  Roland R Griffiths; Ethan S Hurwitz; Alan K Davis; Matthew W Johnson; Robert Jesse
Journal:  PLoS One       Date:  2019-04-23       Impact factor: 3.240

9.  The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs.

Authors:  Robin L Carhart-Harris; Robert Leech; Peter J Hellyer; Murray Shanahan; Amanda Feilding; Enzo Tagliazucchi; Dante R Chialvo; David Nutt
Journal:  Front Hum Neurosci       Date:  2014-02-03       Impact factor: 3.169

Review 10.  Superior pattern processing is the essence of the evolved human brain.

Authors:  Mark P Mattson
Journal:  Front Neurosci       Date:  2014-08-22       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.